Close Window

Digital Look Email A Friend

GSK and CureVac secure $740m payout in mRNA patent settlement

Published by Iain Gilbert on 8th August 2025

(Sharecast News) - Drugmaker GSK said on Friday that it had reached a settlement, alongside CureVac, to resolve long-running patent litigation with BioNTech and Pfizer over mRNA-based COVID-19 vaccines.

URL: http://www.digitallook.com/dl/news/story/35273794/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.